|
Market Closed -
NYSE
16:00:02 2026-10-13 EDT
|
5-day change | 1st Jan Change | ||
| 45.55 USD | +0.42% |
|
-3.76% | +12.19% |
| 09-21 | Avantor Names Todd Garner as CFO | MT |
| 09-04 | CONMED Corporation Announces Voluntary Recall of Genesys Crossft Suture Anchor | CI |
Company Valuation: CONMED Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,146 | 2,702 | 3,368 | 2,114 | 1,257 | 1,359 | - | - |
| Change | - | -34.83% | 24.64% | -37.22% | -40.53% | 8.06% | - | - |
| Enterprise Value (EV) 1 | 4,810 | 3,728 | 4,317 | 2,995 | 2,051 | 2,100 | 1,997 | 1,878 |
| Change | - | -22.5% | 15.81% | -30.62% | -31.52% | 2.37% | -4.93% | -5.95% |
| P/E | 73.1x | -33.1x | 53.7x | 16.1x | 26.9x | 11.7x | 10.1x | 9.47x |
| PBR | 5.26x | 3.57x | 4.04x | 2.2x | 1.1x | 1.19x | 1.04x | 0.91x |
| PEG | - | 0x | -0x | 0x | -0.4x | 0x | 0.6x | 1.42x |
| Capitalization / Revenue | 4.1x | 2.58x | 2.71x | 1.62x | 0.91x | 0.99x | 0.95x | 0.9x |
| EV / Revenue | 4.76x | 3.57x | 3.47x | 2.29x | 1.49x | 1.54x | 1.39x | 1.24x |
| EV / EBITDA | 24.4x | 19.8x | 18.3x | 11.3x | 7.44x | 7.5x | 6.77x | 5.98x |
| EV / EBIT | 33.6x | 28.4x | 24.8x | 14.8x | 9.5x | 9.81x | 8.81x | 7.48x |
| EV / FCF | 49.6x | 322x | 40.6x | 19.5x | 13.6x | 9.81x | 12.1x | 11.2x |
| FCF Yield | 2.01% | 0.31% | 2.46% | 5.14% | 7.36% | 10.2% | 8.24% | 8.89% |
| Dividend per Share 2 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | - | - | - |
| Rate of return | 0.56% | 0.9% | 0.73% | 1.17% | 1.97% | - | - | - |
| EPS 2 | 1.94 | -2.68 | 2.04 | 4.25 | 1.51 | 3.88 | 4.49 | 4.79 |
| Distribution rate | 41.2% | -29.9% | 39.2% | 18.8% | 53% | - | - | - |
| Net sales 1 | 1,011 | 1,045 | 1,245 | 1,307 | 1,375 | 1,367 | 1,434 | 1,511 |
| EBITDA 1 | 197.2 | 188.7 | 235.4 | 265.6 | 275.9 | 280 | 295 | 314 |
| EBIT 1 | 143.3 | 131.3 | 174.4 | 202.8 | 216 | 214 | 226.6 | 250.9 |
| Net income 1 | 62.54 | -80.58 | 64.46 | 132.4 | 47.06 | 116.7 | 135 | 142.6 |
| Net Debt 1 | 663.8 | 1,026 | 949.6 | 881.3 | 794.1 | 741.5 | 637.9 | 519.2 |
| Reference price 2 | 141.76 | 88.64 | 109.51 | 68.44 | 40.60 | 45.36 | 45.36 | 45.36 |
| Nbr of stocks (in thousands) | 29,247 | 30,482 | 30,752 | 30,891 | 30,968 | 29,951 | - | - |
| Announcement Date | 1/26/22 | 2/2/23 | 1/31/24 | 2/5/25 | 1/28/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 11.69x | 1.54x | 7.5x | -.--% | 1.36B | |
| 29.81x | 3.99x | 15.41x | 2.52% | 176B | |
| 19.66x | 3.56x | 12.74x | 3.06% | 118B | |
| 22x | 4.32x | 15.07x | 1.27% | 108B | |
| 25.99x | 2.56x | 10.26x | 2.76% | 75.34B | |
| 17.8x | 0.21x | 12.98x | 0.73% | 62.03B | |
| 30.51x | 7.58x | 19.51x | 1.31% | 52.8B | |
| 36.4x | 3.49x | 11.96x | 2.08% | 51.45B | |
| 35.48x | 8.82x | 24.71x | -.--% | 41.28B | |
| 48.26x | 1.32x | 12.25x | 0.2% | 31.37B | |
| Average | 27.76x | 3.74x | 14.24x | 1.39% | 71.78B | |
| Weighted average by Cap. | 27.15x | 3.88x | 14.61x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CNMD Stock
- Valuation CONMED Corporation
Select your edition
All financial news and data tailored to specific country editions
